Cannapharmarx (CPMD) Stock Statistics & Valuation Metrics

Cannapharmarx has a market cap or net worth of $2.85M. The enterprise value is $27.84M.

Cannapharmarx has 662,501,400 shares outstanding. The number of shares has decreased by -2.65% in one year.

Cannapharmarx’s return on equity (ROE) is 0.37 and return on invested capital (ROIC) is 31.87%.

The current PE Ratio of Cannapharmarx is ―. Cannapharmarx’s PEG ratio is -0.01.

In the last 12 months, Cannapharmarx had revenue of 1.36M and earned -11.13M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was -2.03M and capital expenditures 0.00, giving a free cash flow of -2.03M billion.

Cannapharmarx pays an annual dividend of ―, resulting in a dividend yield of ―

Cannapharmarx upcoming earnings date is May 19, 2026, TBA (Confirmed).

Cannapharmarx as a current ratio of 0.04, with Debt / Equity ratio of -111.00%

In the past 12 months, Cannapharmarx has paid 0.00 in taxes.

Cannapharmarx EV to EBITDA ratio is -5.23, with an EV/FCF ratio of 0.00.

Cannapharmarx has $927.00 in cash and marketable securities with $24.99M in debt, giving a net cash position of -$24.99M billion.

Gross margin is -190.85%, with operating margin of -245.77%, and net profit margin of -817.19%.

The average price target for Cannapharmarx is ―, which is 11.43% higher than the current price. The consensus rating is ―